Skip to content
Inciteful Med

Understanding Congenital Antithrombin Deficiency

Last updated:

Congenital antithrombin deficiency is a rare genetic condition that increases your risk of developing blood clots like DVT or pulmonary embolism. While the lifetime risk is high, working with your doctor on a proactive management plan using blood thinners can safely protect your long-term health.

Key Takeaways

  • • Congenital antithrombin deficiency is a rare, inherited condition that significantly increases the risk of abnormal blood clots.
  • • The condition is caused by a SERPINC1 gene mutation that stops your body's natural clot-preventing proteins from working correctly.
  • • While the lifetime risk of a blood clot is high without intervention, proactive medical management drastically lowers this risk.
  • • Treatment may involve daily blood thinners or targeted preventative care during high-risk periods like surgery, pregnancy, and long flights.
  • • Having the genetic mutation does not guarantee you will suffer a blood clot, especially when following a specialized medical roadmap.

Learning you have Congenital Antithrombin Deficiency (also known as Antithrombin III Deficiency) can feel overwhelming. You may have heard it described as a “severe” condition, but it is important to remember that a genetic risk is not a guaranteed medical event. This diagnosis is a tool that allows you and your care team to take proactive, protective steps for your long-term health.

What Is Congenital Antithrombin Deficiency?

This is a rare, inherited condition caused by a mutation in the SERPINC1 gene [1][2]. It follows an autosomal dominant inheritance pattern, which means if one parent has the gene, there is a 50% chance of passing it to their children [1].

In a typical body, antithrombin acts like a natural “brake” for the blood clotting process by neutralizing proteins like thrombin and Factor Xa [3]. When you have this deficiency, your body either doesn’t produce enough of this protein (Type I) or produces a version that doesn’t work correctly (Type II) [4][5].

Understanding the Risk

Antithrombin deficiency is considered the most potent of the inherited thrombophilias (conditions that increase the risk of blood clots) [6][2].

  • Lifetime Risk: The estimated lifetime risk of developing a Venous Thromboembolism (VTE)—which includes Deep Vein Thrombosis (DVT) in the legs or a Pulmonary Embolism (PE) in the lungs—is between 50% and 90% [7]. While an unmanaged 50% to 90% risk sounds frightening, remember that this number reflects what happens without modern medical care. With a proactive management plan, your personal risk can be significantly lowered.
  • Rarity: It is rare, affecting approximately 1 in 2,000 to 1 in 5,000 people in the general population [1][8].
  • Severity Comparison: While more common conditions like Factor V Leiden increase clot risk by 3 to 7 times, antithrombin deficiency can increase the risk by up to 20 times compared to the general population [9][10].

Gene vs. Clot: You are in Control

It is vital to distinguish between having the gene and having a clot. Many people live for decades without ever knowing they have this condition until they are tested because of a relative’s diagnosis [11].

While the genetic risk is permanent, the actual event of a blood clot is often “triggered” by specific situations. By knowing your diagnosis, you can manage these high-risk windows:

  1. Surgery and Injury: Major physical trauma or surgery increases clot risk; doctors can use specialized treatments like antithrombin concentrate during these times [7][12].
  2. Pregnancy and Postpartum: The risk is significantly higher during and immediately after pregnancy. Early planning with a specialist ensures both parent and baby stay safe [13][14].
  3. Immobility: Long flights or extended bed rest are known triggers where extra precautions (like compression socks or temporary medication) are used [15].

Managing Your Future

A diagnosis is not a crisis; it is a roadmap. Depending on your personal history, your doctor may recommend:

  • Prophylaxis: Taking medication only during “high-risk” events like those listed above [13].
  • Long-term Anticoagulation: Taking a daily “blood thinner” (like Warfarin or newer DOACs) to maintain a steady level of protection [6][16].
  • Family Screening: Helping close relatives get tested so they can also benefit from proactive care [17].

The goal of management is to ensure that your diagnosis remains a line in your medical chart rather than an interruption to your life.

Frequently Asked Questions

What is the difference between Type I and Type II antithrombin deficiency?
Type I means your body does not produce enough of the antithrombin protein. Type II means you produce normal amounts of the protein, but it does not function correctly to stop the blood clotting process.
How high is the risk of getting a blood clot with antithrombin deficiency?
Without medical management, the lifetime risk of developing a venous thromboembolism (like a DVT or pulmonary embolism) is between 50% and 90%. However, with proactive care and proper medication, this personal risk can be significantly lowered.
Do I need to take a daily blood thinner if I have antithrombin deficiency?
Not everyone requires daily blood thinners. Depending on your personal history, your doctor may recommend long-term medication or only prescribe preventative blood thinners during high-risk events like surgery, pregnancy, or prolonged immobility.
Can I pass congenital antithrombin deficiency to my children?
Yes, it follows an autosomal dominant inheritance pattern. This means if you have the genetic mutation, there is a 50% chance of passing it on to each of your children.
How is surgery managed for someone with antithrombin deficiency?
Because physical trauma and surgery increase the risk of blood clots, doctors can use specialized treatments like antithrombin concentrate along with standard blood thinners. This protocol ensures you are protected during the procedure and your recovery.

Questions for Your Doctor

  • • Based on my blood work, do I have Type I (not enough antithrombin) or Type II (antithrombin that doesn't work correctly) deficiency?
  • • What is my specific antithrombin activity level, and how does that number influence my daily risk?
  • • Do I need to be on a 'blood thinner' (anticoagulant) every day, or only during high-risk times like surgery or long-distance travel?
  • • If I ever need surgery or have a major injury, what is the protocol for using antithrombin concentrate instead of just standard blood thinners?
  • • At what age should my children or other close relatives be tested for this condition?
  • • Are newer medications like DOACs (e.g., Eliquis or Xarelto) appropriate for my specific case, or is Warfarin still the preferred option?

Questions for You

  • • Was I diagnosed because I had a blood clot, or was it found during family screening?
  • • Am I currently planning for any major life events that increase risk, such as surgery, pregnancy, or a job that requires frequent long-distance travel?
  • • How do I feel about the idea of long-term medication? What are my main concerns about taking a daily 'blood thinner'?
  • • Have any of my close biological relatives (parents, siblings, children) ever had a blood clot, especially at a young age?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    New genetic variant in the SERPINC1 gene: hereditary Antithrombin deficiency case report, familial thrombosis and considerations on genetic counseling.

    Polyak ME, Zaklyazminskaya EV

    BMC medical genetics 2020; (21(1)):73 doi:10.1186/s12881-020-01001-5.

    PMID: 32252658
  2. 2

    Five Challenging Cases of Hereditary Antithrombin Deficiency Characterized by Thrombosis or Complicated Pregnancy.

    Roberts JC, von Drygalski A, Zhou JY, et al.

    Journal of blood medicine 2022; (13()):611-618 doi:10.2147/JBM.S365996.

    PMID: 36303565
  3. 3

    Association of hereditary antithrombin deficiency with intrauterine growth restriction.

    Said HM, El-Gharbawi NM, Moneim SEAE, Hafez AA

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2018; (29(5)):442-445 doi:10.1097/MBC.0000000000000740.

    PMID: 29889663
  4. 4

    Pulmonary thromboembolism associated with hereditary antithrombin III deficiency: A case report.

    Liu J, Wang Y, Rong C, et al.

    Medicine 2024; (103(10)):e37429 doi:10.1097/MD.0000000000037429.

    PMID: 38457560
  5. 5

    Diagnostic Performance of Commercial Antithrombin Activity Assays: Do We Get What We Expect?

    Orlando C, Drèze C, Evenepoel A, et al.

    Thrombosis and haemostasis 2025; doi:10.1055/a-2628-4046.

    PMID: 40473262
  6. 6

    Issues in the Diagnosis and Management of Hereditary Antithrombin Deficiency.

    Bauer KA, Nguyen-Cao TM, Spears JB

    The Annals of pharmacotherapy 2016; (50(9)):758-67 doi:10.1177/1060028016651276.

    PMID: 27281301
  7. 7

    Management of Venous Thromboembolism in Patients with Hereditary Antithrombin Deficiency and Pregnancy: Case Report and Review of the Literature.

    Refaei M, Xing L, Lim W, et al.

    Case reports in hematology 2017; (2017()):9261351 doi:10.1155/2017/9261351.

    PMID: 28168066
  8. 8

    Clinical Phenotype and Genetic Analysis of a Family with Hereditary Antithrombin Deficiency Caused by SERPINC1 Gene Mutation.

    Zhao Y, Du L, Lin S, et al.

    Thrombosis and haemostasis 2026; (126(1)):87-94 doi:10.1055/a-2558-8193.

    PMID: 40097149
  9. 9

    Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.

    van Vlijmen EF, Wiewel-Verschueren S, Monster TB, Meijer K

    Journal of thrombosis and haemostasis : JTH 2016; (14(7)):1393-403 doi:10.1111/jth.13349.

    PMID: 27121914
  10. 10

    Atypical pulmonary thromboembolism caused by the mutation site SERPINC1 of the antithrombin III gene: A case report.

    Lin M, Sun X, Wu J

    Medicine 2024; (103(31)):e39175 doi:10.1097/MD.0000000000039175.

    PMID: 39093784
  11. 11

    Hereditary Antithrombin Deficiency Presenting with Deep Venous Thrombosis During the Second Pregnancy.

    Yamashita M, Komaki T, Tashiro K, et al.

    Internal medicine (Tokyo, Japan) 2020; (59(2)):235-239 doi:10.2169/internalmedicine.3268-19.

    PMID: 31554754
  12. 12

    Race against clots: the challenges of managing antithrombin deficiency in the ICU.

    Giglio Jimenez A, Aravena P, Ibañez V, Ferre A

    BMJ case reports 2024; (17(12)) doi:10.1136/bcr-2024-263287.

    PMID: 39950628
  13. 13

    Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis.

    Croles FN, Nasserinejad K, Duvekot JJ, et al.

    BMJ (Clinical research ed.) 2017; (359()):j4452 doi:10.1136/bmj.j4452.

    PMID: 29074563
  14. 14

    Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium.

    Gerhardt A, Scharf RE, Greer IA, Zotz RB

    Blood 2016; (128(19)):2343-2349 doi:10.1182/blood-2016-03-703728.

    PMID: 27613196
  15. 15

    Thrombophilia Screening: Universal, Selected, or Neither?

    Colucci G, Tsakiris DA

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2017; (23(8)):893-899 doi:10.1177/1076029616683803.

    PMID: 28049358
  16. 16

    Dabigatran in Cerebral Sinus Vein Thrombosis and Thrombophilia.

    Kellermair L, Zeller MWG, Kulyk C, et al.

    Life (Basel, Switzerland) 2022; (12(7)) doi:10.3390/life12070970.

    PMID: 35888060
  17. 17

    Hereditary Antithrombin Deficiency Presenting with Cerebral Venous Thrombosis in Three Members of a Family.

    Ashraf VV, Salam KA, Kizhedath R, Puthussery K

    Neurology India 2023; (71(5)):984-986 doi:10.4103/0028-3886.388110.

    PMID: 37929439

This page is for informational purposes only and does not replace professional medical advice. Always consult a hematologist or healthcare provider to discuss your specific blood clot risks and management plan.

Stay up to date

Get notified when new research about Hereditary thrombophilia due to congenital antithrombin deficiency is published.

No spam. Unsubscribe anytime.